| Stage | TALO | % of rev | CRC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $665M | 100.00% | $1.3B | 100.00% | CRC ×1.95 |
| Gross profit | $509M | 76.58% | $1.2B | 95.76% | CRC +19.2pp |
| Operating income | $198M | 29.82% | $511M | 39.40% | CRC +9.6pp |
| Pre-tax income | $195M | 29.29% | $458M | 35.31% | CRC +6.0pp |
| Net income | $150M | 22.55% | $514M | 39.63% | CRC +17.1pp |
| Stage | TALO | CRC | Gap · A − B |
|---|---|---|---|
| Revenue | $665M100.00% | $1.3B100.00% | CRC ×1.95 |
| Gross profit | 76.58%$509M | 95.76%$1.2B | CRC +19.2pp |
| Operating income | 29.82%$198M | 39.40%$511M | CRC +9.6pp |
| Pre-tax income | 29.29%$195M | 35.31%$458M | CRC +6.0pp |
| Net income |
| 22.55%$150M |
| 39.63%$514M |
| CRC +17.1pp |
No disclosed counterparties: CRC.
None